Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.
06:06
00:41
02:25
01:26
01:25
00:56
00:47
02:18
01:27
02:36
00:40
01:20
00:41
00:28
01:22
01:03
02:09
00:58
00:53
01:18
01:26
00:40
01:03
02:29
00:57
02:22
00:47
01:22
01:08
01:01
02:59
01:49
00:49
02:23
00:50
02:26
01:53
00:45
01:09
00:55
00:41
01:20
01:18
01:03
01:01
00:27
01:15
01:30
02:37
00:40
00:40
00:30
01:15
00:17
02:26
00:47
00:28
00:52
00:33
01:05
01:52
01:36
01:46
01:23
01:07
00:55
01:41
01:04
02:26
03:03
02:30
01:49
02:14
01:27
02:03
01:21
07:58
00:29
01:08
01:21
02:36
01:46
01:02
01:28
01:57
01:03
02:00
03:34
01:30
00:51
02:02
00:51
02:07
02:05
01:36
01:23
02:26
01:11
00:28
01:38
02:14
01:18
01:09
01:23
01:26
01:35
01:07
02:52
05:07
01:11
01:01
01:42
01:55
01:29
00:59
00:49
00:57
01:41
02:09
01:36